FY 1998 Financial Report

You can read this report in its original form here. MAPS IRS Form 990 for 1998 in PDF format Fiscal Year June 1, 1997 — May 31, 1998 (FY 97-98) was a strong year for MAPS with a combination of important …

The Concord Prison Experiment Experiment Follow-Up

Investigator: Rick Doblin, Ph.D. This study, originally published in the Journal of Psychoactive Drugs [Oct-Dec 1998] is one in a series of long-term follow-ups to early psychedelic research that MAPS …

FY 1997 Financial Report

You can read this report in its original form here. MAPS' income in FY 96-97 was $558,683. FY 96-97 represented a dramatic increase in income, expenditures and number of projects over FY 95- 96. FY …

NIH Workshop on the Medical Utility of Marijuana

MAPS report(Turning Protests into Protocols: Dr. Harter´s Legacy) to NIDA’s Expert Panel on Medical Marijuana Research – submitted February 25, 1997 following the February 19-20, 1997 …

After Proposition 200 and 215

December 2, 1996 Senate Judiciary Committee Hearing on Medical Marijuana – A message to new visitors of the MAPS website. MAPS Policy in Response to Prop. 200 and Prop. 215

Families Who Value Psychedelics

In this section of the Rites of Passage project, families share their experiences creating their own contexts for psychedelics and marijuana. Just as each family is unique, each of the following accounts …

NIH Grant Application Process

NIH August 1996 Rejection and Critique of "Smoked Marijuana for HIV-Associated Anorexia and Wasting Protocol"

Water Pipe Study

Water Pipe Study by Dale H. Gieringer, Ph.D. (Summer 1996) Why Marijuana Harm Reduction? by Dale H. Gieringer, Ph.D. (Summer 1996)

FY 1996 Financial Report

This past fiscal year, which ran from June 1, 1995 to May 31, 1996, was MAPS' tenth and most successful ever in terms of both fund-raising and membership. I believe that at least part of this increasing …

Human Psychopharmacology of Psilocybin

Investigator: Rick Strassman, MD University of New Mexico, USA Psychobiological study. Phase 1 dose-response study Sponsor: NIDA Begun, not completed due to personal reasons unrelated to study itself. …

Psilocybin’s Effects on Cognition

Investigator: Manfred Spitzer, MD, PhD et al. Psychiatrische Universitats Klinic, Heidelberg, Germany Human clinical study, completed and published. More psilocybin research in Germany Spitzer M, et al. …